{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-008270","form_type":"8-K","ticker":"PAYS","cik":"0001496443","company_name":"Paysign, Inc.","filed_at":"2025-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.551933+00:00","generated_at":"2026-05-16T21:05:45.220997+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Paysign Q3 revenue $21.6M (+41.6% YoY); raises full-year 2025 guidance","bullets":["Q3 2025 revenue $21.6M (+41.6% YoY); net income $2.22M (+54.2% YoY); diluted EPS $0.04 vs $0.03 YoY.","Adjusted EBITDA $5.04M (23.3% margin), up 78.1% YoY; pharma patient affordability revenue surged 141.9% to $7.92M.","Plasma revenue grew 12.4% to $12.86M; exited with 595 plasma centers (down 12 QoQ) and 105 active pharma programs (up 8 QoQ).","Raises FY2025 guidance: revenue $80.5M–$81.5M (38.7% YoY midpoint), net income $7.0M–$8.0M, Adjusted EBITDA $19.0M–$20.0M.","Ended quarter with $7.53M unrestricted cash, zero bank debt; opened new 30,000 sq ft customer service center."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-008270","json":"https://secwatch.observer/filing/0001683168-25-008270.json","markdown":"https://secwatch.observer/filing/0001683168-25-008270.md","text":"https://secwatch.observer/filing/0001683168-25-008270.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1496443/000168316825008270/0001683168-25-008270-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1496443/000168316825008270/paysign_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T21:05:45.220997+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}